Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 42 results

Search term: MF = 'C_{32}H_{30}F_{3}N_{5}O_{3}'
123
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
12526263

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-24(23-11-12-26-27(17-23)43-20-42-26)36-29-19-25(37-40(28)29)31(41)39-15-13-38(14-16-39)30(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,24,28,30,36H,13-16,18,20H2
C32H30F3N5O3589.6075201400
21340762

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-25(23-11-12-26-27(17-23)43-20-42-26)37-30-24(19-36-40(28)30)31(41)39-15-13-38(14-16-39)29(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,25,28-29,37H,13-16,18,20H2
C32H30F3N5O3589.6075161200
22232597
InChI=1/C32H30F3N5O3/c1-38-25-10-3-2-9-24(25)37-27(38)12-15-36-29(41)21-13-16-39(17-14-21)26-11-5-8-23-28(26)31(43)40(30(23)42)19-20-6-4-7-22(18-20)32(33,34)35/h2-11,18,21H,12-17,19H2,1H3,(H,36,41)
C32H30F3N5O3589.607510800
115277029

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-41-22-13-9-20(10-14-22)37-27-19-30-28(18-26(27)39-25-7-5-17-36-31(25)42-2)38-24-6-3-4-8-29(24)40(30)21-11-15-23(16-12-21)43-32(33,34)35/h3-8,11-12,15-20,22,39H,9-10,13-14H2,1-2H3
C32H30F3N5O3589.60754400
4504780

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-24(23-11-12-26-27(17-23)43-20-42-26)36-29-19-25(37-40(28)29)31(41)39-15-13-38(14-16-39)30(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,24,28,30,37H,13-16,18,20H2
C32H30F3N5O3589.60754200
123963075

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-41-22-13-9-20(10-14-22)37-27-19-30-28(18-26(27)39-25-7-5-17-36-31(25)42-2)38-24-6-3-4-8-29(24)40(30)21-11-15-23(16-12-21)43-32(33,34)35/h3-8,11-12,15-20,22,39H,9-10,13-14H2,1-2H3/b37-27-
C32H30F3N5O3589.60753300
76781547

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C32H30F3N5O3/c1-18-22(19-6-3-2-4-7-19)13-24(28(42)40(18)17-30(9-10-30)32(33,34)35)38-27(41)21-12-20-14-31(15-25(20)37-16-21)23-8-5-11-36-26(23)39-29(31)43/h2-8,11-12,16,18,22,24H,9-10,13-15,17H2,1H3,(H,38,41)(H,36,39,43)/t18-,22-,24+,31+/m1/s1
C32H30F3N5O3589.60753300
28665312

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-41-22-13-9-20(10-14-22)37-27-19-30-28(18-26(27)39-25-7-5-17-36-31(25)42-2)38-24-6-3-4-8-29(24)40(30)21-11-15-23(16-12-21)43-32(33,34)35/h3-8,11-12,15-20,22,39H,9-10,13-14H2,1-2H3/b37-27+
C32H30F3N5O3589.60753200
4504569

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-25(23-11-12-26-27(17-23)43-20-42-26)37-30-24(19-36-40(28)30)31(41)39-15-13-38(14-16-39)29(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,25,28-29,36H,13-16,18,20H2
C32H30F3N5O3589.60753100
903367
InChI=1/C32H30F3N5O3/c1-43-29-10-3-2-9-28(29)40-16-14-39(15-17-40)27-12-11-25(19-26(27)31(42)37-21-22-6-5-13-36-20-22)38-30(41)23-7-4-8-24(18-23)32(33,34)35/h2-13,18-20H,14-17,21H2,1H3,(H,37,42)(H,38,41)
C32H30F3N5O3589.60752100
31139237
InChI=1/C32H30F3N5O3/c1-20-3-4-22(19-40-15-13-26(41)14-16-40)17-28(20)38-30(42)24-5-9-25(10-6-24)37-31-36-18-21(2)29(39-31)23-7-11-27(12-8-23)43-32(33,34)35/h3-12,17-18H,13-16,19H2,1-2H3,(H,38,42)(H,36,37,39)
C32H30F3N5O3589.60752200
62471543

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-25(23-11-12-26-27(17-23)43-20-42-26)37-30-24(19-36-40(28)30)31(41)39-15-13-38(14-16-39)29(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,25,28-29,37H,13-16,18,20H2/t25-,28+/m1/s1
C32H30F3N5O3589.60752200
62544189

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-24(23-11-12-26-27(17-23)43-20-42-26)36-29-19-25(37-40(28)29)31(41)39-15-13-38(14-16-39)30(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,24,28,30,36H,13-16,18,20H2/t24-,28+/m0/s1
C32H30F3N5O3589.60752200
62581649

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C32H30F3N5O3/c33-32(34,35)28-18-24(23-11-12-26-27(17-23)43-20-42-26)36-29-19-25(37-40(28)29)31(41)39-15-13-38(14-16-39)30(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-12,17,19,24,28,30,36H,13-16,18,20H2/t24-,28+/m1/s1
C32H30F3N5O3589.60752200
17598340
InChI=1/C32H30F3N5O3/c1-21-29(31(42)38-24-8-10-28(11-9-24)43-20-25-7-3-4-12-36-25)18-26(19-37-21)39-30(41)22-15-23(32(33,34)35)17-27(16-22)40-13-5-2-6-14-40/h3-4,7-12,15-19H,2,5-6,13-14,20H2,1H3,(H,38,42)(H,39,41)
C32H30F3N5O3589.60751100
100623463

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-19(2)20-8-12-22(13-9-20)26-16-28(32(33,34)35)40-29(37-26)17-27(39-40)30(41)38-36-18-24-6-4-5-7-25(24)21-10-14-23(15-11-21)31(42)43-3/h4-15,17-19,26,28,37H,16H2,1-3H3,(H,38,41)/b36-18-
C32H30F3N5O3589.60751100
100623464

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-19(2)20-11-13-21(14-12-20)26-16-28(32(33,34)35)40-29(37-26)17-27(39-40)30(41)38-36-18-24-7-4-5-10-25(24)22-8-6-9-23(15-22)31(42)43-3/h4-15,17-19,26,28,37H,16H2,1-3H3,(H,38,41)/b36-18-
C32H30F3N5O3589.60751100
100624124

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-19(2)21-8-12-24(13-9-21)26-16-28(32(33,34)35)40-29(37-26)17-27(39-40)30(41)38-36-18-20-4-6-22(7-5-20)23-10-14-25(15-11-23)31(42)43-3/h4-15,17-19,26,28,37H,16H2,1-3H3,(H,38,41)/b36-18-
C32H30F3N5O3589.60751100
100624133

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C32H30F3N5O3/c1-19(2)21-12-14-23(15-13-21)26-16-28(32(33,34)35)40-29(37-26)17-27(39-40)30(41)38-36-18-20-8-10-22(11-9-20)24-6-4-5-7-25(24)31(42)43-3/h4-15,17-19,26,28,37H,16H2,1-3H3,(H,38,41)/b36-18-
C32H30F3N5O3589.60751100
123

Advertisement